The global cancer stem cells market size is expected to reach USD 3.1 billion by 2030., expanding at a CAGR of 12.09% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells.
Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.
Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.
This product will be delivered within 1-3 business days.
Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.
Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.
Cancer Stem Cells Market Report Highlights
- Nutraceuticals dominated the market in 2022 with a revenue share of 60%, owing to the changing consumer preferences from chemical-based ingredients to organic and herbal ingredients in dietary supplements
- Online stores is anticipated to be the fastest-growing distribution channel segment over the forecast period, owing to the increase in penetration of e-commerce and the rising number of players offering their products online
- North America dominated the Cancer Stem Cells market for cannabidiol consumer health products, with a revenue share of around 70% in 2022.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Mode of action
1.1.2. Cancer forms
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.1.1. Mode of action
1.1.2. Cancer forms
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Mode of action
2.2.2. Cancer forms
2.2.3. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Mode of action
2.2.2. Cancer forms
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Cancer Stem Cells Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.5. Cancer Stem Cells Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic Landscape
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.5. Cancer Stem Cells Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic Landscape
Chapter 4. Cancer Stem Cells: Mode of Action Estimates & Trend Analysis
4.1. Cancer Stem Cells Market: Key Takeaways
4.2. Cancer Stem Cells Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Targeted Cancerous Stem Cells (CSCs)
4.3.1. Targeted cancerous stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. By anti-cancer stem cell therapeutics
4.3.1.1.1. By anti-cancer stem cell therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1. Pathway inhibitors
4.3.1.1.1.1.1. Pathway inhibitors market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.1. WNT signaling pathway
4.3.1.1.1.1.1.1.1. WNT signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.2. Hedgehog signaling pathway
4.3.1.1.1.1.1.2.1. Hedgehog signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.3. Notch signaling pathway
4.3.1.1.1.1.1.3.1. Notch signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.4. Others
4.3.1.1.1.1.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.2. Surface marker-based
4.3.1.1.1.2.1. Surface marker-based market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.3. Immuno-evasion & targeting tumor microenvironment
4.3.1.1.1.3.1. Immuno-evasion & targeting tumor microenvironment market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.4. Nanoparticle-based therapies
4.3.1.1.1.4.1. Nanoparticle-based therapies market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.5. Others
4.3.1.1.1.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2. By-products
4.3.1.2.1. By products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.1. Cell culturing
4.3.1.2.1.1.1. Cell culturing market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.2. Cell Separation
4.3.1.2.1.2.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.3. Cell Analysis
4.3.1.2.1.3.1. Cell analysis market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.4. Molecular analysis
4.3.1.2.1.4.1. Molecular analysis market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.5. Others
4.3.1.2.1.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Stem Cell-based Cancer Therapy
4.4.1. Stem cell-based cancer therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.1. Autologous stem cell transplant
4.4.1.1.1. Autologous stem cell transplant market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2. Allogeneic stem cell transplant
4.4.1.2.1. Allogeneic stem cell transplant market estimates and forecasts, 2018 to 2030 (USD Million)
4.2. Cancer Stem Cells Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Targeted Cancerous Stem Cells (CSCs)
4.3.1. Targeted cancerous stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. By anti-cancer stem cell therapeutics
4.3.1.1.1. By anti-cancer stem cell therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1. Pathway inhibitors
4.3.1.1.1.1.1. Pathway inhibitors market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.1. WNT signaling pathway
4.3.1.1.1.1.1.1.1. WNT signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.2. Hedgehog signaling pathway
4.3.1.1.1.1.1.2.1. Hedgehog signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.3. Notch signaling pathway
4.3.1.1.1.1.1.3.1. Notch signaling pathway market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.1.1.4. Others
4.3.1.1.1.1.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.2. Surface marker-based
4.3.1.1.1.2.1. Surface marker-based market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.3. Immuno-evasion & targeting tumor microenvironment
4.3.1.1.1.3.1. Immuno-evasion & targeting tumor microenvironment market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.4. Nanoparticle-based therapies
4.3.1.1.1.4.1. Nanoparticle-based therapies market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1.1.5. Others
4.3.1.1.1.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2. By-products
4.3.1.2.1. By products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.1. Cell culturing
4.3.1.2.1.1.1. Cell culturing market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.2. Cell Separation
4.3.1.2.1.2.1. Cell separation market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.3. Cell Analysis
4.3.1.2.1.3.1. Cell analysis market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.4. Molecular analysis
4.3.1.2.1.4.1. Molecular analysis market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.2.1.5. Others
4.3.1.2.1.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Stem Cell-based Cancer Therapy
4.4.1. Stem cell-based cancer therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.1. Autologous stem cell transplant
4.4.1.1.1. Autologous stem cell transplant market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.1.2. Allogeneic stem cell transplant
4.4.1.2.1. Allogeneic stem cell transplant market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cancer Stem Cells: Cancer Forms Estimates & Trend Analysis
5.1. Cancer Stem Cells Market: Key Takeaways
5.2. Cancer Stem Cells Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Breast Cancer
5.3.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Blood Cancer
5.4.1. Blood cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Lung Cancer
5.5.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Brain Cancer
5.6.1. Brain cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Colorectal Cancer
5.7.1. Colorectal cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Pancreatic Cancer
5.8.1. Pancreatic cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Bladder Cancer
5.9.1. Bladder cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Liver Cancer
5.10.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Other Cancer
5.11.1. Other cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.2. Cancer Stem Cells Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Breast Cancer
5.3.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Blood Cancer
5.4.1. Blood cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Lung Cancer
5.5.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Brain Cancer
5.6.1. Brain cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Colorectal Cancer
5.7.1. Colorectal cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Pancreatic Cancer
5.8.1. Pancreatic cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Bladder Cancer
5.9.1. Bladder cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Liver Cancer
5.10.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Other Cancer
5.11.1. Other cancer market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cancer Stem Cells Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Cancer Stem Cells Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.2. Cancer Stem Cells Market by Region: Key Marketplace Takeaway
6.3. North America
6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.6. Sweden
6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.7. Norway
6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.4.8. Denmark
6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. Saudi Arabia
6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.2. South Africa
6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Thermo Fisher Scientific, Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic initiatives
7.2.2. AbbVie, Inc.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Merck KGaA
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Bionomics
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Lonza
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Stemline Therapeutics, Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Miltenyi Biotec
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. PromoCell GmbH
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. MacroGenics, Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. FUJIFILM Irvine Scientific
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. STEMCELL Technologies.
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Sino Biological, Inc.
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Lineage Cell Therapeutics, Inc.
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2. Market Participant Categorization
7.2.1. Thermo Fisher Scientific, Inc.
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic initiatives
7.2.2. AbbVie, Inc.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Merck KGaA
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Bionomics
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Lonza
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Stemline Therapeutics, Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Miltenyi Biotec
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. PromoCell GmbH
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. MacroGenics, Inc.
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. FUJIFILM Irvine Scientific
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. STEMCELL Technologies.
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Sino Biological, Inc.
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Lineage Cell Therapeutics, Inc.
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 3 North America cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 4 North America cancer stem cells market, by region, 2018-2030 (USD Million)
Table 5 U.S. cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 6 U.S. cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 7 Canada cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 8 Canada cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 9 Europe cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 10 Europe cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 11 Europe cancer stem cells market, by region, 2018-2030 (USD Million)
Table 12 UK cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 13 UK cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 14 Germany cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 15 Germany cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 16 France cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 17 France cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 18 Italy cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 19 Italy cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 20 Spain cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 21 Spain cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 22 Sweden cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 23 Sweden cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 24 Norway cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 25 Norway cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 26 Denmark cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 27 Denmark cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 28 Asia Pacific cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 29 Asia Pacific cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 30 Asia Pacific cancer stem cells market, by region, 2018-2030 (USD Million)
Table 31 Japan cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 32 Japan cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 33 China cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 34 China cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 35 India cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 36 India cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 37 Australia cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 38 Australia cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 39 Thailand cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 40 Thailand cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 41 South Korea cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 42 South Korea cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 43 Latin America cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 44 Latin America cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 45 Latin America cancer stem cells market, by region, 2018-2030 (USD Million)
Table 46 Brazil cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 47 Brazil cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 48 Mexico cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 49 Mexico cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 50 Argentina cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 51 Argentina cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 52 Middle East and Africa cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 53 Middle East and Africa cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 54 Middle East and Africa cancer stem cells market, by region, 2018-2030 (USD Million)
Table 55 Saudi Arabia cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 56 Saudi Arabia cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 57 South Africa cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 58 South Africa cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 59 UAE cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 60 UAE cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 61 Kuwait cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 62 Kuwait cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 2 North America cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 3 North America cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 4 North America cancer stem cells market, by region, 2018-2030 (USD Million)
Table 5 U.S. cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 6 U.S. cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 7 Canada cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 8 Canada cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 9 Europe cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 10 Europe cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 11 Europe cancer stem cells market, by region, 2018-2030 (USD Million)
Table 12 UK cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 13 UK cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 14 Germany cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 15 Germany cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 16 France cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 17 France cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 18 Italy cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 19 Italy cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 20 Spain cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 21 Spain cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 22 Sweden cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 23 Sweden cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 24 Norway cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 25 Norway cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 26 Denmark cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 27 Denmark cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 28 Asia Pacific cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 29 Asia Pacific cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 30 Asia Pacific cancer stem cells market, by region, 2018-2030 (USD Million)
Table 31 Japan cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 32 Japan cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 33 China cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 34 China cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 35 India cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 36 India cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 37 Australia cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 38 Australia cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 39 Thailand cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 40 Thailand cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 41 South Korea cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 42 South Korea cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 43 Latin America cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 44 Latin America cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 45 Latin America cancer stem cells market, by region, 2018-2030 (USD Million)
Table 46 Brazil cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 47 Brazil cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 48 Mexico cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 49 Mexico cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 50 Argentina cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 51 Argentina cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 52 Middle East and Africa cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 53 Middle East and Africa cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 54 Middle East and Africa cancer stem cells market, by region, 2018-2030 (USD Million)
Table 55 Saudi Arabia cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 56 Saudi Arabia cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 57 South Africa cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 58 South Africa cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 59 UAE cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 60 UAE cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
Table 61 Kuwait cancer stem cells market, by mode of action, 2018-2030 (USD Million)
Table 62 Kuwait cancer stem cells market, by cancer forms, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cancer stem cells: Market outlook
Fig. 9 Cancer stem cells: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Cancer stem cells market driver impact
Fig. 15 Cancer stem cells market restraint impact
Fig. 16 Cancer stem cells strategic initiatives analysis
Fig. 17 Cancer stem cells market: Mode of action movement analysis
Fig. 18 Cancer stem cells market: Mode of action outlook and key takeaways
Fig. 19 Targeted cancerous stem cells market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 By anti-cancer stem cell therapeutics market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Pathway inhibitors market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 WNT signaling pathway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 Hedgehog signaling pathway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 24 Notch signaling pathway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Surface marker-based market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Immuno-evasion & targeting tumor microenvironment market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Nanoparticle-based therapies market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 By product market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Cell culturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Cell separation market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Cell analysis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Molecular analysis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Stem cell-based cancer therapy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 37 Autologous stem cell transplant market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 Allogeneic stem cell transplant market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Cancer stem cells market: Cancer forms movement analysis
Fig. 40 Cancer stem cells market: Cancer forms outlook and key takeaways
Fig. 41 Breast cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Blood cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 Lung cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 Brain cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Colorectal cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Pancreatic cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Bladder cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Liver cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Other cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Global cancer stem cells market: Regional movement analysis
Fig. 51 Global cancer stem cells market: Regional outlook and key takeaways
Fig. 52 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 67 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 69 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 71 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 72 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 73 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 74 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 75 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 76 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 77 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 78 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 79 Kuwait market estimates and forecasts, 2018-2030 (USD Million)
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Cancer stem cells: Market outlook
Fig. 9 Cancer stem cells: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Cancer stem cells market driver impact
Fig. 15 Cancer stem cells market restraint impact
Fig. 16 Cancer stem cells strategic initiatives analysis
Fig. 17 Cancer stem cells market: Mode of action movement analysis
Fig. 18 Cancer stem cells market: Mode of action outlook and key takeaways
Fig. 19 Targeted cancerous stem cells market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 By anti-cancer stem cell therapeutics market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Pathway inhibitors market estimates and forecasts, 2018-2030 (USD Million)
Fig. 22 WNT signaling pathway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 23 Hedgehog signaling pathway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 24 Notch signaling pathway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 Surface marker-based market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Immuno-evasion & targeting tumor microenvironment market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 Nanoparticle-based therapies market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 By product market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Cell culturing market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Cell separation market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 Cell analysis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 Molecular analysis market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Stem cell-based cancer therapy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 37 Autologous stem cell transplant market estimates and forecasts, 2018-2030 (USD Million)
Fig. 38 Allogeneic stem cell transplant market estimates and forecasts, 2018-2030 (USD Million)
Fig. 39 Cancer stem cells market: Cancer forms movement analysis
Fig. 40 Cancer stem cells market: Cancer forms outlook and key takeaways
Fig. 41 Breast cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Blood cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 43 Lung cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 44 Brain cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 Colorectal cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Pancreatic cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Bladder cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 Liver cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Other cancer market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 Global cancer stem cells market: Regional movement analysis
Fig. 51 Global cancer stem cells market: Regional outlook and key takeaways
Fig. 52 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 67 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 69 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 71 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 72 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 73 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 74 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 75 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 76 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 77 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 78 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 79 Kuwait market estimates and forecasts, 2018-2030 (USD Million)
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- AbbVie, Inc.
- Merck KGaA
- Bionomics
- Lonza
- Stemline Therapeutics, Inc.
- Miltenyi Biotec
- PromoCell GmbH
- MacroGenics, Inc.
- FUJIFILM Irvine Scientific
- STEMCELL Technologies.
- Sino Biological, Inc.
- Lineage Cell Therapeutics, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.24 Billion |
| Forecasted Market Value ( USD | $ 3.1 Billion |
| Compound Annual Growth Rate | 12.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
